Recognizing the increasing demand for PDCI expertise and the growing needs of our clients, we are proud to announce the addition of new staff in our Health Technology Assessment (HTA) and Reimbursement Strategy Teams.

Background

Our vision at PDCI is to be the most trusted and valued pricing and reimbursement strategic partner. To ensure we continue to meet the strategic needs of our customers through the ever-changing Canadian reimbursement landscape, our HTA and Reimbursement Strategy teams have grown.

HTA Team – New Staff

• Biostatistician – Keira Robinson, MSc, Epidemiology and Biostatistics, McGill University; Postgraduate Diploma, Biostatistics, University of Sydney.
  • Keira joins PDCI as Manager, HTA and Biostatistics. With over 15 years of quantitative analysis experience, Keira applies her knowledge of statistics, health technology assessment and systematic review methodologies to meta-analyses, utility valuations, critical appraisal of epidemiological studies and quantitative health care research. Her experience ranges across a variety of therapeutic areas, and prior to joining PDCI, Keira worked as a Senior Analyst in biostatistics for THEMA consulting in Sydney, Australia.
• Health Economic Modeler – Brittany Humphries, PhD, Health Research Methodology–HTA, McMaster University (in progress); MSc, Pharmaceutical Sciences-Pharmacoepidemiology, Laval University.
  • Brittany joins PDCI as Associate, HTA and Health Economics. Brittany brings experience in developing economic evaluations (i.e. cost-utility, budget impact), systematic literature reviews and meta-analyses, and other qualitative and quantitative analyses for health technologies in Canada. Over the past year, Brittany has been working as a freelance consultant on projects for the World Health Organization, Doctors Without Borders and the Bruyère Research Institute. Brittany is also English/French bilingual.

• Clinical Evaluation Analyst – Nicole Morse, MSc Pathology and Molecular Medicine, Queens University.

• • Nicole joins PDCI as Analyst, HTA and Clinical Evaluation. Nicole bring with her over 3 years of clinical and basic research experience, and a passion for health care research. Nicole has recently completed her MSc at Queens University.

Reimbursement Strategy Team – New Staff

• Market Access and Policy Research – Denise Prindiville, MBA, Simon Fraser University; BSc, University of British Columbia, Cell Biology and Medical Genetics.
  • Denise joins PDCI as Manager, Market Access and Policy Research. Bringing exceptional pan-Canadian experience to PDCI, Denise has worked within Public and Private market access, Pharmaceuticals, Medical Devices, Patient Support Programs and Government Health Services. Her experience of over 15 years includes a current Board of Directors position with an Ontario Family Health Team, as well as previous experience implementing provincial immunization programs, health technology assessments, epidemiology, and health equity assessments. With increasing interest among clients in Real World Evidence and Patient Support Programs, Denise’s past work in patient access navigation, and privacy impact assessments offer further valuable insights for our clients.

Please join us in welcoming Keira, Brittany, Nicole, and Denise to the team!

To discuss how PDCI can support your Reimbursement Strategy and HTA Submissions, please contact JP Dowson (jp.dowson@pdci.ca) or Donna Lawrence (donna.lawrence@pdci.ca).